United States ex rel. Dickson v. Bristol-Myers Squibb Co. (In re Plavix Mktg., Sales Practice & Prods. Liab. Litig. (NO. II))
District Court, D. New Jersey
1Opinion of the Court
WOLFSON, United States District Judge:
Before the Court is the motion of Defendants Bristol-Myers Squibb Company ("BMS"), Sanofi-Aventis U.S. LLC, Sanofi U.S. Service Inc., and Sanofi-Synthelabo Inc. (collectively "Sanofi") (together with BMS, "Defendants") to dismiss the Fourth *933Amended Complaint ("4AC") of relator Elisa Dickson ("Realtor"). In the 4AC, Relator brings a qui tam action, a member case of the Multi-District Litigation, In re: Plavix Marketing, Sales Practices and Products Liability Litigation, involving the alleged wrongful marketing and sales of Plavix (clopidogrel bisulfate), a…
2Cases cited55 opinions
- Ashcroft v. IqbalSupreme Court of the United States · 2009
- Bell Atlantic Corp. v. TwomblySupreme Court of the United States · 2007
- Foman v. DavisSupreme Court of the United States · 1962
- Scheuer v. RhodesSupreme Court of the United States · 1974
- Phillips v. County of AlleghenyCourt of Appeals for the Third Circuit · 2008
50 more not listed; retrieve them via the Exa API.
3Cited by10 opinions
- United States ex rel. Simpson v. Bayer Corp.District Court, D. New Jersey · 2019
- State ex rel. Balderas v. Bristol-Myers SquibbNew Mexico Court of Appeals · 2018
- BENNETT v. BAYER CORPORATIONDistrict Court, D. New Jersey · 2022
- BENNETT v. BAYER CORPORATIONDistrict Court, D. New Jersey · 2024
- FREEDMAN v. BAYADA HOME HEALTH CARE, INC.District Court, D. New Jersey · 2025
5 more not listed; retrieve them via the Exa API.